Persistent Sweet syndrome post-hematopoietic stem cell transplantation heralding molecular relapse of myelofibrosis

Am J Hematol. 2024 Jun;99(6):1170-1171. doi: 10.1002/ajh.27199. Epub 2023 Dec 28.

Abstract

Persistent Sweet syndrome in a patient with history of myelofibrosis thought to be in remission post-hematopoietic stem cell transplantation leads to diagnosis of molecular relapse of myelofibrosis.

Publication types

  • Case Reports

MeSH terms

  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Middle Aged
  • Primary Myelofibrosis* / genetics
  • Primary Myelofibrosis* / therapy
  • Recurrence*
  • Sweet Syndrome* / etiology
  • Sweet Syndrome* / pathology